메뉴 건너뛰기




Volumn 16, Issue 1, 2015, Pages 30-42

Endocannabinoid signalling and the deteriorating brain

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCANNABINOID;

EID: 84925549946     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn3876     Document Type: Review
Times cited : (303)

References (154)
  • 2
    • 77954598740 scopus 로고    scopus 로고
    • Cannabis based drug is licensed for spasticity in patients with MS
    • Kmietowicz, Z. Cannabis based drug is licensed for spasticity in patients with MS. BMJ 340, c3363 (2010).
    • (2010) BMJ , vol.340 , pp. c3363
    • Kmietowicz, Z.1
  • 3
    • 30444457225 scopus 로고    scopus 로고
    • Cannabinoid pharmacology: The first 66 years
    • Pertwee, R. G. Cannabinoid pharmacology: the first 66 years. Br. J. Pharmacol. 147, S153-S171 (2006).
    • (2006) Br. J. Pharmacol. , vol.147 , pp. S153-S171
    • Pertwee, R.G.1
  • 4
    • 84868131884 scopus 로고    scopus 로고
    • The endocannabinoid system in normal and pathological brain ageing
    • Bilkei-Gorzo, A. The endocannabinoid system in normal and pathological brain ageing. Phil. Trans. R. Soc. B 367, 3326-3341 (2012).
    • (2012) Phil. Trans. R. Soc. B , vol.367 , pp. 3326-3341
    • Bilkei-Gorzo, A.1
  • 5
    • 84903702089 scopus 로고    scopus 로고
    • Therapeutic potential of cannabinoids in neurodegenerative disorders: A selective review
    • Velayudhan, L. et al. Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review. Curr. Pharm. Des. 20, 2218-2230 (2014).
    • (2014) Curr. Pharm. Des. , vol.20 , pp. 2218-2230
    • Velayudhan, L.1
  • 7
    • 0025325535 scopus 로고
    • Structure of a cannabinoid receptor and functional expression of the cloned cDNA
    • Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. & Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564 (1990).
    • (1990) Nature , vol.346 , pp. 561-564
    • Matsuda, L.A.1    Lolait, S.J.2    Brownstein, M.J.3    Young, A.C.4    Bonner, T.I.5
  • 8
    • 0027515373 scopus 로고
    • Molecular characterization of a peripheral receptor for cannabinoids
    • Munro, S., Thomas, K. L. & Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65 (1993).
    • (1993) Nature , vol.365 , pp. 61-65
    • Munro, S.1    Thomas, K.L.2    Abu-Shaar, M.3
  • 9
    • 0027078685 scopus 로고
    • Isolation and structure of a brain constituent that binds to the cannabinoid receptor
    • Devane, W. A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949 (1992).
    • (1992) Science , vol.258 , pp. 1946-1949
    • Devane, W.A.1
  • 10
    • 0029012014 scopus 로고
    • Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
    • Mechoulam, R. et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90 (1995).
    • (1995) Biochem. Pharmacol. , vol.50 , pp. 83-90
    • Mechoulam, R.1
  • 11
    • 0028970517 scopus 로고
    • 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
    • Sugiura, T. et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Commun. 215, 89-97 (1995).
    • (1995) Biochem. Biophys. Commun. , vol.215 , pp. 89-97
    • Sugiura, T.1
  • 12
    • 43249100162 scopus 로고    scopus 로고
    • Targeting the endocannabinoid system: To enhance or reduce?
    • Di Marzo, V. Targeting the endocannabinoid system: to enhance or reduce? Nature Rev. Drug Discov. 7, 438-455 (2008).
    • (2008) Nature Rev. Drug Discov. , vol.7 , pp. 438-455
    • Di Marzo, V.1
  • 13
    • 84863011465 scopus 로고    scopus 로고
    • CNS effects of CB2 cannabinoid receptors: Beyond neuro-immuno-cannabinoid activity
    • Onaivi, E. S., Ishiguro, H., Gu, S.& Liu, Q. R. CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity. J. Psychopharmacol. 26, 92-103 (2012).
    • (2012) J. Psychopharmacol. , vol.26 , pp. 92-103
    • Onaivi, E.S.1    Ishiguro, H.2    Gu, S.3    Liu, Q.R.4
  • 14
    • 33645774927 scopus 로고    scopus 로고
    • Distribution of cannabinoid receptors in the central and peripheral nervous system
    • Mackie, K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp. Pharmacol. 168, 299-325 (2005).
    • (2005) Handb Exp. Pharmacol. , vol.168 , pp. 299-325
    • Mackie, K.1
  • 16
    • 0034058250 scopus 로고    scopus 로고
    • Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: Antagonism by anandamide
    • Gonsiorek, W. et al. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: Antagonism by anandamide. Mol. Pharmacol. 57, 1045-1050 (2000).
    • (2000) Mol. Pharmacol. , vol.57 , pp. 1045-1050
    • Gonsiorek, W.1
  • 17
    • 0028589390 scopus 로고
    • Formation and inactivation of endogenous cannabinoid anandamide in central neurons
    • Di Marzo, V. et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691 (1994).
    • (1994) Nature , vol.372 , pp. 686-691
    • Di Marzo, V.1
  • 18
    • 1242294480 scopus 로고    scopus 로고
    • Molecular characterization of a phospholipase D generating anandamide and its congeners
    • Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T. & Ueda, N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279, 5298-5305 (2004).
    • (2004) J. Biol. Chem. , vol.279 , pp. 5298-5305
    • Okamoto, Y.1    Morishita, J.2    Tsuboi, K.3    Tonai, T.4    Ueda, N.5
  • 19
    • 44049087532 scopus 로고    scopus 로고
    • Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain
    • Simon, G. M. & Cravatt, B. F. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J. Biol. Chem. 283, 9341-9349 (2008).
    • (2008) J. Biol. Chem. , vol.283 , pp. 9341-9349
    • Simon, G.M.1    Cravatt, B.F.2
  • 20
    • 37349020974 scopus 로고    scopus 로고
    • Multiple pathways involved in the biosynthesis of anandamide
    • Liu, J. et al. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology 54, 1-7 (2008).
    • (2008) Neuropharmacology , vol.54 , pp. 1-7
    • Liu, J.1
  • 21
    • 10744229235 scopus 로고    scopus 로고
    • Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
    • Bisogno, T. et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163, 463-468 (2003).
    • (2003) J. Cell Biol. , vol.163 , pp. 463-468
    • Bisogno, T.1
  • 22
    • 75949116246 scopus 로고    scopus 로고
    • The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase - mediates retrograde suppression of synaptic transmission
    • Tanimura, A. et al. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase - mediates retrograde suppression of synaptic transmission. Neuron 65, 320-327 (2010).
    • (2010) Neuron , vol.65 , pp. 320-327
    • Tanimura, A.1
  • 23
    • 38449121568 scopus 로고    scopus 로고
    • Analysis and pharmacological targeting of phospholipase C β interactions with G proteins
    • Lehmann, D. M., Yuan, C. & Smrcka, A. V. Analysis and pharmacological targeting of phospholipase C β interactions with G proteins. Methods Enzymol. 434, 29-48 (2007).
    • (2007) Methods Enzymol. , vol.434 , pp. 29-48
    • Lehmann, D.M.1    Yuan, C.2    Smrcka, A.V.3
  • 24
    • 0031033841 scopus 로고    scopus 로고
    • Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain
    • Cadas, H., di Tomaso, E. & Piomelli, D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17, 1226-1242 (1997).
    • (1997) J. Neurosci. , vol.17 , pp. 1226-1242
    • Cadas, H.1    Di Tomaso, E.2    Piomelli, D.3
  • 25
    • 84876947593 scopus 로고    scopus 로고
    • Transport of endocannabinoids across the plasma membrane and within the cell
    • Fowler, C. J. Transport of endocannabinoids across the plasma membrane and within the cell. FEBS J. 280, 1895-1904 (2013).
    • (2013) FEBS J. , vol.280 , pp. 1895-1904
    • Fowler, C.J.1
  • 26
    • 0029904838 scopus 로고    scopus 로고
    • Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
    • Cravatt, B. F. et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83-87 (1996).
    • (1996) Nature , vol.384 , pp. 83-87
    • Cravatt, B.F.1
  • 27
    • 0036678094 scopus 로고    scopus 로고
    • Brain monoglyceride lipase participating in endocannabinoid inactivation
    • Dinh, T. P. et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl Acad. Sci. USA 99, 10819-10824 (2002).
    • (2002) Proc. Natl Acad. Sci. USA , vol.99 , pp. 10819-10824
    • Dinh, T.P.1
  • 28
    • 77955053537 scopus 로고    scopus 로고
    • The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
    • Marrs, W. R. et al. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nature Neurosci. 13, 951-957 (2010).
    • (2010) Nature Neurosci. , vol.13 , pp. 951-957
    • Marrs, W.R.1
  • 29
    • 37149013708 scopus 로고    scopus 로고
    • A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol
    • Blankman, J. L., Simon, G. M. & Cravatt, B. F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14, 1347-1356 (2007).
    • (2007) Chem. Biol. , vol.14 , pp. 1347-1356
    • Blankman, J.L.1    Simon, G.M.2    Cravatt, B.F.3
  • 30
    • 0037160078 scopus 로고    scopus 로고
    • Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides
    • Kozak, K. R. et al. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J. Biol. Chem. 277, 44877-44885 (2002).
    • (2002) J. Biol. Chem. , vol.277 , pp. 44877-44885
    • Kozak, K.R.1
  • 31
    • 84898872648 scopus 로고    scopus 로고
    • Endocannabinoid-mediated retrograde modulation of synaptic transmission
    • Ohno-Shosaku, T. & Kano, M. Endocannabinoid-mediated retrograde modulation of synaptic transmission. Curr. Opin. Neurobiol. 29, 1-8 (2014).
    • (2014) Curr. Opin. Neurobiol. , vol.29 , pp. 1-8
    • Ohno-Shosaku, T.1    Kano, M.2
  • 33
    • 0033614984 scopus 로고    scopus 로고
    • Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
    • Zygmunt, P. M. et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400, 452-457 (1999).
    • (1999) Nature , vol.400 , pp. 452-457
    • Zygmunt, P.M.1
  • 34
    • 22144477527 scopus 로고    scopus 로고
    • Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation
    • Bouaboula, M. et al. Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation. Eur. J. Pharmacol. 517, 174-181 (2005).
    • (2005) Eur. J. Pharmacol. , vol.517 , pp. 174-181
    • Bouaboula, M.1
  • 36
    • 0032442541 scopus 로고    scopus 로고
    • Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats
    • Berrendero, F. et al. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats. Biochim. Biophys. Acta 1407, 205-214 (1998).
    • (1998) Biochim. Biophys. Acta , vol.1407 , pp. 205-214
    • Berrendero, F.1
  • 37
    • 0028133167 scopus 로고
    • Cannabinoid receptors in developing rats: Detection of mRNA and receptor binding
    • McLaughlin, C. R., Martin, B. R., Compton, D. R. & Abood, M. E. Cannabinoid receptors in developing rats: Detection of mRNA and receptor binding. Drug Alcohol Depend. 36, 27-31 (1994).
    • (1994) Drug Alcohol Depend. , vol.36 , pp. 27-31
    • McLaughlin, C.R.1    Martin, B.R.2    Compton, D.R.3    Abood, M.E.4
  • 38
    • 0037417989 scopus 로고    scopus 로고
    • Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice
    • Wang, L., Liu, J., Harvey-White, J., Zimmer, A. & Kunos, G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl Acad. Sci. USA 100, 1393-1398 (2003).
    • (2003) Proc. Natl Acad. Sci. USA , vol.100 , pp. 1393-1398
    • Wang, L.1    Liu, J.2    Harvey-White, J.3    Zimmer, A.4    Kunos, G.5
  • 39
    • 23244433262 scopus 로고    scopus 로고
    • Regional distribution and age-dependent expression of N-acylphosphatidylethanolamine-hydrolyzing phospholipase D in rat brain
    • Morishita, J. et al. Regional distribution and age-dependent expression of N-acylphosphatidylethanolamine-hydrolyzing phospholipase D in rat brain. J. Neurochem. 94, 753-762 (2005).
    • (2005) J. Neurochem. , vol.94 , pp. 753-762
    • Morishita, J.1
  • 40
    • 0033198288 scopus 로고    scopus 로고
    • Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period
    • Berrendero, F., Sepe, N., Ramos, J. A., Di Marzo, V. & Fernández-Ruiz, J. J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 33, 181-191 (1999).
    • (1999) Synapse , vol.33 , pp. 181-191
    • Berrendero, F.1    Sepe, N.2    Ramos, J.A.3    Di Marzo, V.4    Fernández-Ruiz, J.J.5
  • 41
    • 0037040043 scopus 로고    scopus 로고
    • The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats
    • Wenger, T. et al. The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats. Life Sci. 70, 1407-1414 (2002).
    • (2002) Life Sci. , vol.70 , pp. 1407-1414
    • Wenger, T.1
  • 42
    • 0031047273 scopus 로고    scopus 로고
    • Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
    • Glass, M., Dragunow, M. & Faull, R. L. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77, 299-318 (1997).
    • (1997) Neuroscience , vol.77 , pp. 299-318
    • Glass, M.1    Dragunow, M.2    Faull, R.L.3
  • 43
    • 84862003296 scopus 로고    scopus 로고
    • Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear
    • Choi, K. et al. Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear. J. Psych Res. 46, 882-889 (2012).
    • (2012) J. Psych Res. , vol.46 , pp. 882-889
    • Choi, K.1
  • 44
    • 84867117239 scopus 로고    scopus 로고
    • Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex
    • Long, L. E., Lind, J., Webster, M. & Weickert, C. S. Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex. BMC Neurosci. 13, 87 (2012).
    • (2012) BMC Neurosci. , vol.13 , pp. 87
    • Long, L.E.1    Lind, J.2    Webster, M.3    Weickert, C.S.4
  • 45
    • 0027948317 scopus 로고
    • Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains
    • Westlake, T. M., Howlett, A. C., Bonner, T. I., Matsuda, L. A. & Herkenham, M. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 63, 637-652 (1994).
    • (1994) Neuroscience , vol.63 , pp. 637-652
    • Westlake, T.M.1    Howlett, A.C.2    Bonner, T.I.3    Matsuda, L.A.4    Herkenham, M.5
  • 46
    • 27344450242 scopus 로고    scopus 로고
    • Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors
    • Bilkei-Gorzo, A. et al. Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc. Natl Acad. Sci. USA 102, 15670-15675 (2005).
    • (2005) Proc. Natl Acad. Sci. USA , vol.102 , pp. 15670-15675
    • Bilkei-Gorzo, A.1
  • 47
    • 79960572625 scopus 로고    scopus 로고
    • Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging
    • Albayram, O. et al. Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging. Proc. Natl Acad. Sci. USA 108, 11256-11261 (2011).
    • (2011) Proc. Natl Acad. Sci. USA , vol.108 , pp. 11256-11261
    • Albayram, O.1
  • 48
    • 84885793175 scopus 로고    scopus 로고
    • Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory
    • Albayram, O., Bilkei-Gorzó, A. & Zimmer, A. Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory. Front. Aging Neurosci. 4, 34 (2012).
    • (2012) Front. Aging Neurosci. , vol.4 , pp. 34
    • Albayram, O.1    Bilkei-Gorzó, A.2    Zimmer, A.3
  • 49
    • 84863244650 scopus 로고    scopus 로고
    • Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD
    • Han, J. et al. Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 148, 1039-1050 (2012).
    • (2012) Cell , vol.148 , pp. 1039-1050
    • Han, J.1
  • 50
    • 79959975886 scopus 로고    scopus 로고
    • Verbal learning and memory in adolescent cannabis users, alcohol users and non-users
    • Solowij, N. et al. Verbal learning and memory in adolescent cannabis users, alcohol users and non-users. Psychopharmacology 216, 131-144 (2011).
    • (2011) Psychopharmacology , vol.216 , pp. 131-144
    • Solowij, N.1
  • 51
    • 0037069251 scopus 로고    scopus 로고
    • Dose-related neurocognitive effects of marijuana use
    • Bolla, K. I., Brown, K., Eldreth, D., Tate, K. & Cadet, J. L. Dose-related neurocognitive effects of marijuana use. Neurology 59, 1337-1343 (2002).
    • (2002) Neurology , vol.59 , pp. 1337-1343
    • Bolla, K.I.1    Brown, K.2    Eldreth, D.3    Tate, K.4    Cadet, J.L.5
  • 52
    • 76049114677 scopus 로고    scopus 로고
    • Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use
    • Mata, I. et al. Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use. Brain Res. 1317, 297-304 (2010).
    • (2010) Brain Res. , vol.1317 , pp. 297-304
    • Mata, I.1
  • 53
    • 80054916654 scopus 로고    scopus 로고
    • Cerebellar white-matter changes in cannabis users with and without schizophrenia
    • Solowij, N. et al. Cerebellar white-matter changes in cannabis users with and without schizophrenia. Psychol. Med. 41, 2349-2359 (2011).
    • (2011) Psychol. Med. , vol.41 , pp. 2349-2359
    • Solowij, N.1
  • 54
    • 20444428308 scopus 로고    scopus 로고
    • Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions
    • Lundqvist, T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol. Biochem. Behav. 81, 319-330 (2005).
    • (2005) Pharmacol. Biochem. Behav. , vol.81 , pp. 319-330
    • Lundqvist, T.1
  • 55
    • 57449100592 scopus 로고    scopus 로고
    • The chronic effects of cannabis on memory in humans: A review
    • Solowij, N. & Battisti, R. The chronic effects of cannabis on memory in humans: a review. Curr. Drug Abuse Rev. 1, 81-98 (2008).
    • (2008) Curr. Drug Abuse Rev. , vol.1 , pp. 81-98
    • Solowij, N.1    Battisti, R.2
  • 56
    • 81355139614 scopus 로고    scopus 로고
    • Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1-/- mice
    • e11-22
    • Bilkei-Gorzó, A. et al. Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1-/- mice. Neurobiol. Aging 33, 200.e11-22 (2012).
    • (2012) Neurobiol. Aging , vol.33 , pp. 200
    • Bilkei-Gorzó, A.1
  • 57
    • 31444437185 scopus 로고    scopus 로고
    • Peripheral cannabinoid receptor, CB2, regulates bone mass
    • Ofek, O. et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc. Natl Acad. Sci. USA 103, 696-701 (2006).
    • (2006) Proc. Natl Acad. Sci. USA , vol.103 , pp. 696-701
    • Ofek, O.1
  • 58
    • 38349132542 scopus 로고    scopus 로고
    • Cannabinoid receptors and the regulation of bone mass
    • Bab, I. & Zimmer, A. Cannabinoid receptors and the regulation of bone mass. Br. J. Pharmacol. 153, 182-188 (2008).
    • (2008) Br. J. Pharmacol. , vol.153 , pp. 182-188
    • Bab, I.1    Zimmer, A.2
  • 60
    • 84879205624 scopus 로고    scopus 로고
    • Aging and neurogenesis in the adult forebrain: What we have learned and where we should go from here
    • Hamilton, L. K., Joppé, S. E., Cochard, M. & Fernandes, K. J. L. Aging and neurogenesis in the adult forebrain: what we have learned and where we should go from here. Eur. J. Neurosci. 37, 1978-1986 (2013).
    • (2013) Eur. J. Neurosci. , vol.37 , pp. 1978-1986
    • Hamilton, L.K.1    Joppé, S.E.2    Cochard, M.3    Fernandes, K.J.L.4
  • 61
    • 33749171885 scopus 로고    scopus 로고
    • Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing
    • Molofsky, A. V. et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443, 448-452 (2006).
    • (2006) Nature , vol.443 , pp. 448-452
    • Molofsky, A.V.1
  • 62
    • 0141447477 scopus 로고    scopus 로고
    • Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice
    • Jin, K. et al. Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell 2, 175-183 (2003).
    • (2003) Aging Cell , vol.2 , pp. 175-183
    • Jin, K.1
  • 63
    • 27644433182 scopus 로고    scopus 로고
    • Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
    • Jiang, W. et al. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J. Clin. Invest. 115, 3104-3116 (2005).
    • (2005) J. Clin. Invest. , vol.115 , pp. 3104-3116
    • Jiang, W.1
  • 64
    • 33845603466 scopus 로고    scopus 로고
    • Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
    • Palazuelos, J. et al. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J. 20, 2405-2407 (2006).
    • (2006) FASEB J. , vol.20 , pp. 2405-2407
    • Palazuelos, J.1
  • 65
    • 47749088572 scopus 로고    scopus 로고
    • A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner
    • Goncalves, M. B. et al. A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. Mol. Cell Neurosci. 38, 526-536 (2008).
    • (2008) Mol. Cell Neurosci. , vol.38 , pp. 526-536
    • Goncalves, M.B.1
  • 66
    • 84868125270 scopus 로고    scopus 로고
    • Endocannabinoids via CB- receptors act as neurogenic niche cues during cortical development
    • Díaz-Alonso, J., Guzmán, M. & Galve-Roperh, I. Endocannabinoids via CB- receptors act as neurogenic niche cues during cortical development. Phil. Trans. R. Soc. B 367, 3229-3241 (2012).
    • (2012) Phil. Trans. R. Soc. B , vol.367 , pp. 3229-3241
    • Díaz-Alonso, J.1    Guzmán, M.2    Galve-Roperh, I.3
  • 67
    • 76649137560 scopus 로고    scopus 로고
    • Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice
    • Gao, Y. et al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J. Neurosci. 30, 2017-2024 (2010).
    • (2010) J. Neurosci. , vol.30 , pp. 2017-2024
    • Gao, Y.1
  • 68
    • 81855185433 scopus 로고    scopus 로고
    • DAGL-dependent endocannabinoid signalling: Roles in axonal pathfinding, synaptic plasticity and adult neurogenesis
    • Oudin, M. J., Hobbs, C. & Doherty, P. DAGL-dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis. Eur. J. Neurosci. 34, 1634-1646 (2011).
    • (2011) Eur. J. Neurosci. , vol.34 , pp. 1634-1646
    • Oudin, M.J.1    Hobbs, C.2    Doherty, P.3
  • 69
    • 3342979420 scopus 로고    scopus 로고
    • Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice
    • Jin, K. et al. Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol. Pharmacol. 66, 204-208 (2004).
    • (2004) Mol. Pharmacol. , vol.66 , pp. 204-208
    • Jin, K.1
  • 70
    • 26444557412 scopus 로고    scopus 로고
    • The endocannabinoid system drives neural progenitor proliferation
    • Aguado, T. et al. The endocannabinoid system drives neural progenitor proliferation. FASEB J. 19, 1704-1706 (2005).
    • (2005) FASEB J. , vol.19 , pp. 1704-1706
    • Aguado, T.1
  • 71
    • 84898620219 scopus 로고    scopus 로고
    • Miswiring the brain: 9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway
    • Tortoriello, G. et al. Miswiring the brain: 9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway. EMBO J. 33, 668-685 (2014).
    • (2014) EMBO J. , vol.33 , pp. 668-685
    • Tortoriello, G.1
  • 72
    • 34548696608 scopus 로고    scopus 로고
    • Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2
    • Arévalo-Martín, A. et al. Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2. Eur. J. Neurosci. 26, 1548-1559 (2007).
    • (2007) Eur. J. Neurosci. , vol.26 , pp. 1548-1559
    • Arévalo-Martín, A.1
  • 73
    • 77954406421 scopus 로고    scopus 로고
    • Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas
    • Stella, N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 58, 1017-1030 (2010).
    • (2010) Glia , vol.58 , pp. 1017-1030
    • Stella, N.1
  • 74
    • 78649605467 scopus 로고    scopus 로고
    • Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties
    • Hegde, V. L., Nagarkatti, M. & Nagarkatti, P. S. Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties. Eur. J. Immunol. 40, 3358-3371 (2010).
    • (2010) Eur. J. Immunol. , vol.40 , pp. 3358-3371
    • Hegde, V.L.1    Nagarkatti, M.2    Nagarkatti, P.S.3
  • 75
    • 26844448746 scopus 로고    scopus 로고
    • Modulation of the cannabinoid CB receptor in microglial cells in response to inflammatory stimuli
    • Maresz, K., Carrier, E. J., Ponomarev, E. D., Hillard, C. J. & Dittel, B. N. Modulation of the cannabinoid CB receptor in microglial cells in response to inflammatory stimuli. J. Neurochem. 95, 437-445 (2005).
    • (2005) J. Neurochem. , vol.95 , pp. 437-445
    • Maresz, K.1    Carrier, E.J.2    Ponomarev, E.D.3    Hillard, C.J.4    Dittel, B.N.5
  • 76
    • 58049170379 scopus 로고    scopus 로고
    • Endocannabinoid signaling in microglial cells
    • Stella, N. Endocannabinoid signaling in microglial cells. Neuropharmacology 56, 244-253 (2009).
    • (2009) Neuropharmacology , vol.56 , pp. 244-253
    • Stella, N.1
  • 77
    • 34147165471 scopus 로고    scopus 로고
    • Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
    • Maresz, K. et al. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nature Med. 13, 492-497 (2007).
    • (2007) Nature Med. , vol.13 , pp. 492-497
    • Maresz, K.1
  • 78
    • 70350622421 scopus 로고    scopus 로고
    • Plasma endocannabinoid levels in multiple sclerosis
    • Jean-Gilles, L. et al. Plasma endocannabinoid levels in multiple sclerosis. J. Neurol. Sci. 287, 212-215 (2009).
    • (2009) J. Neurol. Sci. , vol.287 , pp. 212-215
    • Jean-Gilles, L.1
  • 79
    • 33947591537 scopus 로고    scopus 로고
    • The endocannabinoid system in targeting inflammatory neurodegenerative diseases
    • Centonze, D. Finazzi-Agro, A. Bernardi, G. & Maccarrone, M. The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol. Sci. 28, 180-187 (2007).
    • (2007) Trends Pharmacol. Sci. , vol.28 , pp. 180-187
    • Centonze, D.1    Finazzi-Agro, A.2    Bernardi, G.3    Maccarrone, M.4
  • 81
    • 0033911488 scopus 로고    scopus 로고
    • Inflamm-aging. An evolutionary perspective on immunosenescence
    • Franceschi, C. et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. NY Acad. Sci. 908, 244-254 (2000).
    • (2000) Ann. NY Acad. Sci. , vol.908 , pp. 244-254
    • Franceschi, C.1
  • 82
    • 9444277292 scopus 로고    scopus 로고
    • Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis
    • Patel, S. et al. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145, 5431-5438 (2004).
    • (2004) Endocrinology , vol.145 , pp. 5431-5438
    • Patel, S.1
  • 83
    • 79951511304 scopus 로고    scopus 로고
    • Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation
    • Zoppi, S. et al. Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychopharmacology 36, 805-818 (2011).
    • (2011) Neuropsychopharmacology , vol.36 , pp. 805-818
    • Zoppi, S.1
  • 84
    • 84879664081 scopus 로고    scopus 로고
    • Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure
    • Cutando, L. et al. Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure. J. Clin. Invest. 123, 2816-2831 (2013).
    • (2013) J. Clin. Invest. , vol.123 , pp. 2816-2831
    • Cutando, L.1
  • 85
    • 84877734347 scopus 로고    scopus 로고
    • Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH
    • Zhang, G. et al. Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH. Nature 497, 211-216 (2013).
    • (2013) Nature , vol.497 , pp. 211-216
    • Zhang, G.1
  • 86
    • 0035848818 scopus 로고    scopus 로고
    • Leptin-regulated endocannabinoids are involved in maintaining food intake
    • Di Marzo, V. et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410, 822-825 (2001).
    • (2001) Nature , vol.410 , pp. 822-825
    • Di Marzo, V.1
  • 87
    • 77956544806 scopus 로고    scopus 로고
    • At the crossroad between immunity and metabolism: Focus on leptin
    • Conde, J. et al. At the crossroad between immunity and metabolism: focus on leptin. Expert Rev. Clin. Immunol. 6, 801-808 (2010).
    • (2010) Expert Rev. Clin. Immunol. , vol.6 , pp. 801-808
    • Conde, J.1
  • 88
    • 84878996500 scopus 로고    scopus 로고
    • Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons
    • Cristino, L. et al. Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proc. Natl Acad. Sci. USA 110, E2229-E2238 (2013).
    • (2013) Proc. Natl Acad. Sci. USA , vol.110 , pp. E2229-E2238
    • Cristino, L.1
  • 89
    • 77956264569 scopus 로고    scopus 로고
    • Leptin as a metabolic link to multiple sclerosis
    • Matarese, G. et al. Leptin as a metabolic link to multiple sclerosis. Nature Rev. Neurol. 6, 455-461 (2010).
    • (2010) Nature Rev. Neurol. , vol.6 , pp. 455-461
    • Matarese, G.1
  • 90
    • 84891883979 scopus 로고    scopus 로고
    • Hypothalamic mTOR: The rookie energy sensor
    • Martínez de Morentin, P. B. et al. Hypothalamic mTOR: the rookie energy sensor. Curr. Mol. Med. 14, 3-21 (2014).
    • (2014) Curr. Mol. Med. , vol.14 , pp. 3-21
    • Martínez De Morentin, P.B.1
  • 91
    • 69449095814 scopus 로고    scopus 로고
    • Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling
    • Puighermanal, E. et al. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nature Neurosci. 12, 1152-1158 (2009).
    • (2009) Nature Neurosci. , vol.12 , pp. 1152-1158
    • Puighermanal, E.1
  • 92
    • 84878610582 scopus 로고    scopus 로고
    • Dissociation of the Pharmacological Effects of THC by mTOR Blockade
    • Puighermanal, E. et al. Dissociation of the Pharmacological Effects of THC by mTOR Blockade. Neuropsychopharmacology 38, 1334-1343 (2013).
    • (2013) Neuropsychopharmacology , vol.38 , pp. 1334-1343
    • Puighermanal, E.1
  • 93
    • 84877627117 scopus 로고    scopus 로고
    • Targeting the endocannabinoid system in the treatment of fragile X syndrome
    • Busquets-Garcia, A. et al. Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nature Med. 19, 603-607 (2013).
    • (2013) Nature Med. , vol.19 , pp. 603-607
    • Busquets-Garcia, A.1
  • 95
    • 77955747346 scopus 로고    scopus 로고
    • With TOR, less is more: A key role for the conserved nutrient-sensing TOR pathway in aging
    • Kapahi, P. et al. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell. Metab. 11, 453-465 (2010).
    • (2010) Cell. Metab. , vol.11 , pp. 453-465
    • Kapahi, P.1
  • 96
    • 66449115318 scopus 로고    scopus 로고
    • Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
    • Salazar, M. et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 119, 1359-1372 (2009).
    • (2009) J. Clin. Invest. , vol.119 , pp. 1359-1372
    • Salazar, M.1
  • 97
    • 70349651656 scopus 로고    scopus 로고
    • TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action
    • Salazar, M. et al.TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action. Autophagy 57, 1048-1049 (2009).
    • (2009) Autophagy , vol.57 , pp. 1048-1049
    • Salazar, M.1
  • 98
    • 84904296024 scopus 로고    scopus 로고
    • Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium
    • Koay, L. C., Rigby, R. J. & Wright, K. L. Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium. Am. J. Physiol. Gastrointest Liver Physiol. 307, G140-G148 (2014).
    • (2014) Am. J. Physiol. Gastrointest Liver Physiol. , vol.307 , pp. G140-G148
    • Koay, L.C.1    Rigby, R.J.2    Wright, K.L.3
  • 99
    • 84922391805 scopus 로고    scopus 로고
    • Cannabinoid receptor 1 modulates the autophagic flux independent of mTOR- and BECLIN1-complex
    • Hiebel, C., Kromm, T., Stark, M. & Behl, C. Cannabinoid receptor 1 modulates the autophagic flux independent of mTOR- and BECLIN1-complex. J Neurochem. 131, 484-497 (2014).
    • (2014) J Neurochem. , vol.131 , pp. 484-497
    • Hiebel, C.1    Kromm, T.2    Stark, M.3    Behl, C.4
  • 100
    • 84885828571 scopus 로고    scopus 로고
    • Loss of CB1 receptors leads to decreased cathepsin D levels and accelerated lipofuscin accumulation in the hippocampus
    • Piyanova, A. et al. Loss of CB1 receptors leads to decreased cathepsin D levels and accelerated lipofuscin accumulation in the hippocampus. Mech. Ageing Dev. 134, 391-399 (2013).
    • (2013) Mech. Ageing Dev. , vol.134 , pp. 391-399
    • Piyanova, A.1
  • 101
    • 84878775231 scopus 로고    scopus 로고
    • Lipofuscin: Formation, effects and role of macroautophagy
    • Höhn, A. & Grune, T. Lipofuscin: formation, effects and role of macroautophagy. Redox Biol. 1, 140-144 (2013).
    • (2013) Redox Biol. , vol.1 , pp. 140-144
    • Höhn, A.1    Grune, T.2
  • 102
    • 0027176364 scopus 로고
    • The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease
    • Andrew, S. E. et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Gen. 4, 398-403 (1993).
    • (1993) Nature Gen. , vol.4 , pp. 398-403
    • Andrew, S.E.1
  • 104
    • 78650694548 scopus 로고    scopus 로고
    • Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease
    • Blazquez, C. et al. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease. Brain 134, 119-136 (2011).
    • (2011) Brain , vol.134 , pp. 119-136
    • Blazquez, C.1
  • 105
    • 84906672436 scopus 로고    scopus 로고
    • Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice
    • Naydenov, A. V. et al. Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice. Neurobiol. Dis. 71, 140-150 (2014).
    • (2014) Neurobiol. Dis. , vol.71 , pp. 140-150
    • Naydenov, A.V.1
  • 106
    • 84901843938 scopus 로고    scopus 로고
    • A restricted population of CB1 cannabinoid receptors with neuroprotective activity
    • Chiarlone, A. et al. A restricted population of CB1 cannabinoid receptors with neuroprotective activity. Proc. Natl Acad. Sci. USA 111, 8257-8262 (2014).
    • (2014) Proc. Natl Acad. Sci. USA , vol.111 , pp. 8257-8262
    • Chiarlone, A.1
  • 107
    • 78649638441 scopus 로고    scopus 로고
    • Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons
    • Noonan, J. et al. Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons. J. Biol. Chem. 285, 38543-38554 (2010).
    • (2010) J. Biol. Chem. , vol.285 , pp. 38543-38554
    • Noonan, J.1
  • 108
    • 27744562012 scopus 로고    scopus 로고
    • Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells
    • Sarnataro, D. et al. Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. FEBS Lett. 579, 6343-6349 (2005).
    • (2005) FEBS Lett. , vol.579 , pp. 6343-6349
    • Sarnataro, D.1
  • 109
    • 78650033582 scopus 로고    scopus 로고
    • Type i cannabinoid receptor trafficking: All roads lead to lysosome
    • Rozenfeld, R. Type I cannabinoid receptor trafficking: all roads lead to lysosome. Traffic 12, 12-18 (2011).
    • (2011) Traffic , vol.12 , pp. 12-18
    • Rozenfeld, R.1
  • 110
    • 84861225016 scopus 로고    scopus 로고
    • Agonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neurons
    • Brailoiu, G. C. et al. Agonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neurons. Drug Alcohol Depend. 123, 277-281 (2012).
    • (2012) Drug Alcohol Depend. , vol.123 , pp. 277-281
    • Brailoiu, G.C.1
  • 111
    • 84859208807 scopus 로고    scopus 로고
    • Mitochondrial CB1 receptors regulate neuronal energy metabolism
    • Bénard, G. et al. Mitochondrial CB1 receptors regulate neuronal energy metabolism. Nature Neurosci. 15, 558-564 (2012).
    • (2012) Nature Neurosci. , vol.15 , pp. 558-564
    • Bénard, G.1
  • 112
    • 84881276517 scopus 로고    scopus 로고
    • Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria
    • Morozov, Y. M. et al. Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria. Eur. J. Neurosci. 38, 2341-2348 (2013).
    • (2013) Eur. J. Neurosci. , vol.38 , pp. 2341-2348
    • Morozov, Y.M.1
  • 113
    • 84894468110 scopus 로고    scopus 로고
    • Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
    • Witte, M. E., Mahad, D. J., Lassmann, H. & van Horssen, J. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis. Trends Mol. Med. 20, 179-187 (2014).
    • (2014) Trends Mol. Med. , vol.20 , pp. 179-187
    • Witte, M.E.1    Mahad, D.J.2    Lassmann, H.3    Van Horssen, J.4
  • 114
    • 0035979244 scopus 로고    scopus 로고
    • Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
    • Cravatt, B. F. et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl Acad. Sci. USA 98, 9371-9376 (2001).
    • (2001) Proc. Natl Acad. Sci. USA , vol.98 , pp. 9371-9376
    • Cravatt, B.F.1
  • 115
    • 79955958008 scopus 로고    scopus 로고
    • Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance
    • Taschler, U.et al. Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J. Biol. Chem. 286, 17467-17477 (2011).
    • (2011) J. Biol. Chem. , vol.286 , pp. 17467-17477
    • Taschler, U.1
  • 116
    • 35348938494 scopus 로고    scopus 로고
    • Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors
    • Morgese, M. G., Cassano, T., Cuomo, V. & Giuffrida, A. Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. Exp. Neurol. 208, 110-119 (2007).
    • (2007) Exp. Neurol. , vol.208 , pp. 110-119
    • Morgese, M.G.1    Cassano, T.2    Cuomo, V.3    Giuffrida, A.4
  • 117
    • 0037341020 scopus 로고    scopus 로고
    • Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease
    • Lastres-Becker, I. et al. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease. J. Neurochem. 84, 1097-1109 (2003).
    • (2003) J. Neurochem. , vol.84 , pp. 1097-1109
    • Lastres-Becker, I.1
  • 118
    • 0035900694 scopus 로고    scopus 로고
    • Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain
    • Huang, S. M. et al. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem. 276, 42639-42644 (2001).
    • (2001) J. Biol. Chem. , vol.276 , pp. 42639-42644
    • Huang, S.M.1
  • 119
    • 79961105328 scopus 로고    scopus 로고
    • Presence, formation and putative biological activities of N-acyl serotonins, a novel class of fatty-acid derived mediators, in the intestinal tract
    • Verhoeckx, K. C. et al. Presence, formation and putative biological activities of N-acyl serotonins, a novel class of fatty-acid derived mediators, in the intestinal tract. Biochim. Biophys. Acta 1811, 578-586 (2011).
    • (2011) Biochim. Biophys. Acta , vol.1811 , pp. 578-586
    • Verhoeckx, K.C.1
  • 120
    • 70349499007 scopus 로고    scopus 로고
    • The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine
    • Hu, S. S. et al. The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine. Prostaglandins Leukot. Essent. Fatty Acids 81, 291-301 (2009).
    • (2009) Prostaglandins Leukot. Essent. Fatty Acids , vol.81 , pp. 291-301
    • Hu, S.S.1
  • 121
    • 2442642871 scopus 로고    scopus 로고
    • Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus
    • Schmidt-Hieber, C., Jonas, P. & Bischofberger, J. Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus. Nature 429, 184-187 (2004).
    • (2004) Nature , vol.429 , pp. 184-187
    • Schmidt-Hieber, C.1    Jonas, P.2    Bischofberger, J.3
  • 122
    • 84896546138 scopus 로고    scopus 로고
    • Modulation of T-type calcium channels by bioactive lipids
    • Chemin, J., Cazade, M. & Lory, P. Modulation of T-type calcium channels by bioactive lipids. Pflugers Arch. 466, 689-700 (2014).
    • (2014) Pflugers Arch. , vol.466 , pp. 689-700
    • Chemin, J.1    Cazade, M.2    Lory, P.3
  • 123
    • 84901791811 scopus 로고    scopus 로고
    • COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
    • Alhouayek, M. & Muccioli, G. G. COX-2-derived endocannabinoid metabolites as novel inflammatory mediators. Trends Pharmacol. Sci. 35, 284-292 (2014).
    • (2014) Trends Pharmacol. Sci. , vol.35 , pp. 284-292
    • Alhouayek, M.1    Muccioli, G.G.2
  • 124
    • 51649093696 scopus 로고    scopus 로고
    • The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products
    • Woodward, D. F. et al. The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacol. Ther. 120, 71-80 (2008).
    • (2008) Pharmacol. Ther. , vol.120 , pp. 71-80
    • Woodward, D.F.1
  • 125
    • 84887495462 scopus 로고    scopus 로고
    • The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: A potential role of cyclooxygenase-2-dependent metabolism of 2-AG
    • Valdeolivas, S. et al. The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG. Cell Death Dis. 4, e862 (2013).
    • (2013) Cell Death Dis. , vol.4 , pp. e862
    • Valdeolivas, S.1
  • 126
    • 81055156684 scopus 로고    scopus 로고
    • Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation
    • Nomura, D. K. et al. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 334, 809-813 (2011).
    • (2011) Science , vol.334 , pp. 809-813
    • Nomura, D.K.1
  • 127
    • 79952004102 scopus 로고    scopus 로고
    • Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults
    • Chen, X., Zhang, J. & Chen, C. Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults. Neuroscience 178, 159-168 (2011).
    • (2011) Neuroscience , vol.178 , pp. 159-168
    • Chen, X.1    Zhang, J.2    Chen, C.3
  • 128
    • 84870412999 scopus 로고    scopus 로고
    • Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease
    • Chen, R. et al. Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease. Cell Rep. 2, 1329-1339 (2012).
    • (2012) Cell Rep. , vol.2 , pp. 1329-1339
    • Chen, R.1
  • 129
    • 84980052949 scopus 로고    scopus 로고
    • TRPV1: A stress response protein in the central nervous system
    • Ho, K. W., Ward, N. J. & Calkins, D. J. TRPV1: a stress response protein in the central nervous system. Am. J. Neurodegener. Dis. 1, 1-14 (2012).
    • (2012) Am. J. Neurodegener. Dis. , vol.1 , pp. 1-14
    • Ho, K.W.1    Ward, N.J.2    Calkins, D.J.3
  • 130
    • 48149112620 scopus 로고    scopus 로고
    • Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory
    • Li, H. B. et al. Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory. Biol. Psychiatry 64, 286-292 (2008).
    • (2008) Biol. Psychiatry , vol.64 , pp. 286-292
    • Li, H.B.1
  • 131
    • 84887514200 scopus 로고    scopus 로고
    • Oleoylethanolamide reduces l-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson's disease
    • González-Aparicio, R. & Moratalla, R. Oleoylethanolamide reduces l-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson's disease. Neurobiol. Dis. 62, 416-425 (2014).
    • (2014) Neurobiol. Dis. , vol.62 , pp. 416-425
    • González-Aparicio, R.1    Moratalla, R.2
  • 132
    • 84886591048 scopus 로고    scopus 로고
    • Pharmacological blockade of TRPV1 receptors modulates the effects of 6-OHDA on motor and cognitive functions in a rat model of Parkinson's disease
    • Razavinasab, M. et al. Pharmacological blockade of TRPV1 receptors modulates the effects of 6-OHDA on motor and cognitive functions in a rat model of Parkinson's disease. Fundam. Clin. Pharmacol. 27, 632-640 (2013).
    • (2013) Fundam. Clin. Pharmacol. , vol.27 , pp. 632-640
    • Razavinasab, M.1
  • 133
    • 81055130228 scopus 로고    scopus 로고
    • The major central endocannabinoid directly acts at GABAA receptors
    • Sigel, E. et al. The major central endocannabinoid directly acts at GABAA receptors. Proc. Natl Acad. Sci. USA 108, 18150-18155 (2011).
    • (2011) Proc. Natl Acad. Sci. USA , vol.108 , pp. 18150-18155
    • Sigel, E.1
  • 134
    • 79960310251 scopus 로고    scopus 로고
    • Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ
    • Du, H., Chen, X., Zhang, J. & Chen, C. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. Br. J. Pharmacol. 163, 1533-1549 (2011).
    • (2011) Br. J. Pharmacol. , vol.163 , pp. 1533-1549
    • Du, H.1    Chen, X.2    Zhang, J.3    Chen, C.4
  • 135
    • 84904324269 scopus 로고    scopus 로고
    • ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice
    • Naydenov, A. V. et al. ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice. Neuron 83, 361-371 (2014).
    • (2014) Neuron , vol.83 , pp. 361-371
    • Naydenov, A.V.1
  • 136
    • 84888622971 scopus 로고    scopus 로고
    • Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors
    • Pryce, G. et al. Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors. Mult. Scler. 19, 1896-1904 (2013).
    • (2013) Mult. Scler. , vol.19 , pp. 1896-1904
    • Pryce, G.1
  • 137
    • 79960328574 scopus 로고    scopus 로고
    • Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
    • De Petrocellis, L. et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br. J. Pharmacol. 163, 1479-1494 (2011).
    • (2011) Br. J. Pharmacol. , vol.163 , pp. 1479-1494
    • De Petrocellis, L.1
  • 138
    • 84858391237 scopus 로고    scopus 로고
    • Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
    • Leweke, F. M. et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl. Psychiatry 2, e94 (2012).
    • (2012) Transl. Psychiatry , vol.2 , pp. e94
    • Leweke, F.M.1
  • 139
    • 44649195035 scopus 로고    scopus 로고
    • Genetic deletion of fatty acid amide hydrolase results in improved long-term outcome in chronic autoimmune encephalitis
    • Webb, M., Luo, L., Ma, J. Y. & Tham, C. S. Genetic deletion of fatty acid amide hydrolase results in improved long-term outcome in chronic autoimmune encephalitis. Neurosci. Lett. 439, 106-110 (2008).
    • (2008) Neurosci. Lett. , vol.439 , pp. 106-110
    • Webb, M.1    Luo, L.2    Ma, J.Y.3    Tham, C.S.4
  • 140
    • 79960264824 scopus 로고    scopus 로고
    • Cannabinoid CB1 receptors regulate neuronal TNF effects in experimental autoimmune encephalomyelitis
    • Rossi, S. et al. Cannabinoid CB1 receptors regulate neuronal TNF effects in experimental autoimmune encephalomyelitis. Brain Behav. Immun. 25, 1242-1248 (2011).
    • (2011) Brain Behav. Immun. , vol.25 , pp. 1242-1248
    • Rossi, S.1
  • 141
    • 1642320366 scopus 로고    scopus 로고
    • Amnesia induced by β-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade
    • Mazzola, C., Micale, V. & Drago, F. Amnesia induced by β-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. Eur. J. Pharmacol. 477, 219-225 (2003).
    • (2003) Eur. J. Pharmacol. , vol.477 , pp. 219-225
    • Mazzola, C.1    Micale, V.2    Drago, F.3
  • 142
    • 21744461614 scopus 로고    scopus 로고
    • A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease
    • van der Stelt, M. et al. A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. FASEB J. 19, 1140-1142 (2005).
    • (2005) FASEB J. , vol.19 , pp. 1140-1142
    • Van Der Stelt, M.1
  • 143
    • 84873293388 scopus 로고    scopus 로고
    • Downregulation of cannabinoid receptor 1 from neuropeptide y interneurons in the basal ganglia of patients with Huntington's disease and mouse models
    • Horne, E. A. et al. Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models. Eur. J. Neurosci. 37, 429-440 (2013).
    • (2013) Eur. J. Neurosci. , vol.37 , pp. 429-440
    • Horne, E.A.1
  • 144
    • 68349152770 scopus 로고    scopus 로고
    • Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease
    • Dowie, M. J. et al. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. Neuroscience 163, 456-465 (2009).
    • (2009) Neuroscience , vol.163 , pp. 456-465
    • Dowie, M.J.1
  • 145
    • 33845683331 scopus 로고    scopus 로고
    • Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice
    • Bilsland, L. G. et al. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. FASEB J. 20, 1003-1005 (2006).
    • (2006) FASEB J. , vol.20 , pp. 1003-1005
    • Bilsland, L.G.1
  • 146
    • 84874737408 scopus 로고    scopus 로고
    • Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus
    • Steindel, F. et al. Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus. J. Neurochem. 124, 795-807 (2013).
    • (2013) J. Neurochem. , vol.124 , pp. 795-807
    • Steindel, F.1
  • 147
    • 33745327044 scopus 로고    scopus 로고
    • Endocannabinoids and β-amyloid-induced neurotoxicity in vivo: Effect of pharmacological elevation of endocannabinoid levels
    • van der Stelt, M. et al. Endocannabinoids and β-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell. Mol. Life Sci. 63, 1410-1424 (2006).
    • (2006) Cell. Mol. Life Sci. , vol.63 , pp. 1410-1424
    • Van Der Stelt, M.1
  • 148
    • 79953672641 scopus 로고    scopus 로고
    • Molecular reorganization of endocannabinoid signalling in Alzheimer's disease
    • Mulder, J. et al. Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. Brain. 134, 1041-1060 (2011).
    • (2011) Brain. , vol.134 , pp. 1041-1060
    • Mulder, J.1
  • 149
    • 84879990830 scopus 로고    scopus 로고
    • In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system
    • Bari, M. et al. In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system. FEBS J. 280, 3376-3388 (2013).
    • (2013) FEBS J. , vol.280 , pp. 3376-3388
    • Bari, M.1
  • 150
    • 78751482833 scopus 로고    scopus 로고
    • Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease
    • Johnston, T. H. et al. Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease. J. Pharmacol. Exp. Ther. 336, 423-430 (2011).
    • (2011) J. Pharmacol. Exp. Ther. , vol.336 , pp. 423-430
    • Johnston, T.H.1
  • 151
    • 84871027393 scopus 로고    scopus 로고
    • Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease
    • Bouchard, J. et al. Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease. J. Neurosci. 32, 18259-18268 (2012).
    • (2012) J. Neurosci. , vol.32 , pp. 18259-18268
    • Bouchard, J.1
  • 152
    • 79960317325 scopus 로고    scopus 로고
    • Prospects for cannabinoid therapies in basal ganglia disorders
    • Fernandez-Ruiz, J. et al. Prospects for cannabinoid therapies in basal ganglia disorders. Br. J. Pharmacol. 163, 1365-1378 (2011).
    • (2011) Br. J. Pharmacol. , vol.163 , pp. 1365-1378
    • Fernandez-Ruiz, J.1
  • 153
    • 33746261289 scopus 로고    scopus 로고
    • AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis
    • Kim, K., Moore, D. H., Makriyannis, A. & Abood, M. E. AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis. Eur. J. Pharmacol. 542, 100-105 (2006).
    • (2006) Eur. J. Pharmacol. , vol.542 , pp. 100-105
    • Kim, K.1    Moore, D.H.2    Makriyannis, A.3    Abood, M.E.4
  • 154
    • 33644952242 scopus 로고    scopus 로고
    • Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease
    • Gonzalez, S. et al. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease. Brain Res. 1073-1074, 209-219 (2006).
    • (2006) Brain Res. , vol.1073-1074 , pp. 209-219
    • Gonzalez, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.